论文部分内容阅读
高危人乳头瘤病毒(HR-HPV)检测已推荐作为一种细胞学或辅助细胞学的替代方法用于宫颈癌筛查。本研究旨在评估欧洲人群中HR-HPV感染的年龄特点和与细胞学诊断之间的关系。纳入研究的7366例妇女来自瑞士西区,年龄13～96岁。均接受宫颈标本细胞学和HR-HPV检查。收集的标本于48h内
High-risk human papillomavirus (HR-HPV) testing has been recommended as a cytologic or helper cytological alternative to cervical cancer screening. This study was designed to assess the age-specific HR-HPV infection in European populations and its relationship to cytologic diagnosis. The 7366 women included in the study were from Western Switzerland, aged 13-96 years. All received cervical specimen cytology and HR-HPV examination. Collected specimens within 48h